You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T Cell Infusion

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

Not yet recruiting
  • Stage IIIB(N2) Non-small Cell Lung Cancer
  • +3 more
  • Pembrolizumab 200 mg IV infusion
  • Beijing, Beijing, China
    Peking University
May 30, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Jun 5, 2023

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

Recruiting
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Variant
  • CD22CART cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Bio-CAR-T BS Study

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • +2 more
    • Brescia, Italy
      ASST Spedali Civili di Brescia
    May 5, 2022

    T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

    Terminated
    Has Results
    • T-cell Non-Hodgkin Lymphoma
    • Boston, Massachusetts
    • +1 more
    Jan 26, 2023

    Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

    Recruiting
    • Acute Myeloid Leukemia in Children
    • CIML NK Cell Infusion
    • CD3+ T Cell Product Infusion
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 26, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)

    Suspended
    • Acute Myeloid Leukemia
    • +4 more
    • CD8+ Memory T Cell Infusion
    • +5 more
    • Stanford, California
      Stanford Medical Center
    Sep 23, 2021

    Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • iC9.GD2.CAR.IL-15 T Infusion
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Nov 16, 2022

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

    Recruiting
    • Hematologic Malignancies
    • RD13-02 cell infusion
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jun 26, 2023

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022

    Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 6, 2023

    Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

    Recruiting
    • Kidney Cancer
    • cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 2, 2022

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

    Not yet recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Oct 13, 2023

    Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

    Recruiting
    • Solid Tumor
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 31, 2023

    CS1+ or BCMA+ Multiple Myeloma Trial in Wuhan (Conditioning chemo followed by CAR T cell infusion)

    Recruiting
    • CS1+ or BCMA+ Multiple Myeloma
    • Conditioning chemotherapy followed by CAR T cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Feb 11, 2022

    Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

    Not yet recruiting
    • Cytomegalovirus
    • Adenovirus
    • VST infusion
    • CliniMACS
    • Memphis, Tennessee
      St . Jude Children's Research Hospital
    Jan 9, 2023

    Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

    Completed
    • Haematological Malignancies
    • CD25/71 allodepleted donor T-cells
    • London, United Kingdom
    • +1 more
    Jul 18, 2022

    COVID19, ARDS Trial in United States (CK0802, Placebo)

    Completed
    • COVID19
    • ARDS
    • CK0802
    • Placebo
    • Baltimore, Maryland
    • +4 more
    Mar 8, 2022

    Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

    Recruiting
    • Fanconi Anemia
    • +2 more
    • Total Body Irradiation (TBI) (Plan 1)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Infusion of iNKT cells and CD8+T cells
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center
    May 6, 2022

    Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

    Not yet recruiting
    • Islet Transplantation
    • Infusion of recipient T regulatory cell
    • Infusion of concomitant Donor Derived Vertebral Bone Marrow
    • Palo Alto, California
      Stanford University
    Jul 25, 2023

    Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

    Terminated
    • Metastatic Pancreatic Carcinoma
    • CAR2 Anti-CEA CAR-T cells
    • Providence, Rhode Island
      Roger Williams Medical Center
    Jan 12, 2023